Budapest, Hungary

Zsuzsanna Orr


Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1986-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Zsuzsanna Orr: Pioneering Innovations in Pharmaceuticals**

Introduction

Zsuzsanna Orr, an accomplished inventor based in Budapest, Hungary, has made significant contributions to the pharmaceutical industry. With two patents to her name, she has demonstrated a strong commitment to advancing healthcare through innovative solutions.

Latest Patents

Her latest patents include groundbreaking work on iminothiazolidine derivatives. This invention introduces novel iminothiazolidine derivatives defined by a specific molecular formula, where R1 and R3 can independently represent hydrogen or a lower alkyl group. Furthermore, Zsuzsanna has developed pharmaceutical compositions with antianginal activity. These compositions showcase enhanced effectiveness and a more favorable therapeutic index compared to the reference compound, Prenylamine. The preparations include various forms such as tablets, dragees, capsules, and injectable solutions that contain these innovative compounds as active ingredients.

Career Highlights

Zsuzsanna Orr's career has been largely intertwined with Egis Gyógyszergyár, where she has utilized her expertise to drive pharmaceutical innovation. Her work focuses on the development of new therapies aimed at improving patient outcomes, particularly in cardiovascular health.

Collaborations

Throughout her career, Zsuzsanna has collaborated with notable professionals, including Lujza E Petocz and Katalin Grasser. These partnerships foster a collaborative environment that enhances the potential for groundbreaking discoveries and advancements within the pharmaceutical field.

Conclusion

Zsuzsanna Orr's contributions to pharmaceutical innovations exemplify the essential role of inventors in improving healthcare. Her patents reflect a commitment to developing new therapies that can significantly impact patient health and well-being. As she continues her work at Egis Gyógyszergyár, Zsuzsanna remains a key figure in the ongoing evolution of the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…